These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21360849)

  • 1. In-vitro/in-vivo studies of the biodegradable poly-(D,L-lactide-co-glycolide) microspheres of a novel luteinizing hormone-releasing hormone antagonist for prostate cancer treatment.
    Du L; Mei X; Wang C; Li X; Zhang F; Jin Y
    Anticancer Drugs; 2011 Mar; 22(3):262-72. PubMed ID: 21360849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel in vitro release technique for peptide containing biodegradable microspheres.
    Kostanski JW; DeLuca PP
    AAPS PharmSciTech; 2000 Mar; 1(1):E4. PubMed ID: 14727853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
    Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R
    Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.
    Schwach G; Oudry N; Delhomme S; Lück M; Lindner H; Gurny R
    Eur J Pharm Biopharm; 2003 Nov; 56(3):327-36. PubMed ID: 14602174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
    Kavas A; Keskin D; Altunbaş K; Tezcaner A
    Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment.
    Zhang G; Wang T; Gao L; Quan D
    Int J Pharm; 2013 Jun; 450(1-2):138-44. PubMed ID: 23623791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process.
    Ruan G; Feng SS; Li QT
    J Control Release; 2002 Dec; 84(3):151-60. PubMed ID: 12468218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
    Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
    J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G; Qiu W; DeLuca PP
    Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro release study of mono-PEGylated growth hormone-releasing peptide-6 from PLGA microspheres.
    Park EJ; Na DH; Lee KC
    Int J Pharm; 2007 Oct; 343(1-2):281-3. PubMed ID: 17644286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Orntide microspheres in a rat animal model and correlation to in vitro release profiles.
    Kostanski JW; Dani BA; Reynolds GA; Bowers CY; DeLuca PP
    AAPS PharmSciTech; 2000 Oct; 1(4):E27. PubMed ID: 14727892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.
    Kostanski JW; Thanoo BC; DeLuca PP
    Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying.
    Shi NQ; Zhou J; Walker J; Li L; Hong JKY; Olsen KF; Tang J; Ackermann R; Wang Y; Qin B; Schwendeman A; Schwendeman SP
    J Control Release; 2020 May; 321():756-772. PubMed ID: 31935481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative degradation study of biodegradable microspheres of poly(DL-lactide-co-glycolide) with poly(ethyleneglycol) derivates.
    Garcia JT; Fariña JB; Munguía O; Llabrés M
    J Microencapsul; 1999; 16(1):83-94. PubMed ID: 9972505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of biodegradable microspheres of testosterone with poly(D,L-lactide-co-glycolide) and test of drug release in vitro.
    Shen ZR; Zhu JH; Ma Z; Wang F; Wang ZY
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):57-64. PubMed ID: 10676577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performance.
    Schwach G; Oudry N; Giliberto JP; Broqua P; Lück M; Lindner H; Gurny R
    Eur J Pharm Biopharm; 2004 May; 57(3):441-6. PubMed ID: 15093591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.